Liyan Cui

654 total citations
35 papers, 489 citations indexed

About

Liyan Cui is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Liyan Cui has authored 35 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Rheumatology. Recurrent topics in Liyan Cui's work include Systemic Lupus Erythematosus Research (5 papers), Extracellular vesicles in disease (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). Liyan Cui is often cited by papers focused on Systemic Lupus Erythematosus Research (5 papers), Extracellular vesicles in disease (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). Liyan Cui collaborates with scholars based in China, Japan and United States. Liyan Cui's co-authors include Jiajia Zheng, Shuo Yang, Jiao Qiao, Yali Zhang, Jie Zhang, Wenzhe Si, Katsunori Hanamura, Preechar Karin, Tao Wang and Jiansuo Zhou and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and British journal of surgery.

In The Last Decade

Liyan Cui

30 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Liyan Cui China	14	182	86	75	68	58	35	489
Jiayu Duan China	15	144 0.8×	64 0.7×	172 2.3×	54 0.8×	41 0.7×	60	702
Haoming Song China	13	195 1.1×	81 0.9×	27 0.4×	77 1.1×	52 0.9×	56	552
Jonas Carlson Sweden	26	219 1.2×	125 1.5×	75 1.0×	38 0.6×	78 1.3×	98	2.1k
Zhi-Yu Duan China	13	138 0.8×	39 0.5×	198 2.6×	49 0.7×	88 1.5×	32	486
Wanpeng Wang China	15	326 1.8×	33 0.4×	86 1.1×	53 0.8×	138 2.4×	51	749
Songtao Feng China	14	288 1.6×	156 1.8×	148 2.0×	45 0.7×	119 2.1×	34	744
Litao Ruan China	15	90 0.5×	99 1.2×	45 0.6×	41 0.6×	68 1.2×	53	488
Chengzhi Yang China	16	215 1.2×	63 0.7×	18 0.2×	59 0.9×	44 0.8×	64	894
Tomoaki Takata Japan	14	160 0.9×	88 1.0×	156 2.1×	27 0.4×	28 0.5×	70	667

Countries citing papers authored by Liyan Cui

Since Specialization

Citations

This map shows the geographic impact of Liyan Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyan Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyan Cui more than expected).

Fields of papers citing papers by Liyan Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liyan Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyan Cui. The network helps show where Liyan Cui may publish in the future.

Co-authorship network of co-authors of Liyan Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Liyan Cui. A scholar is included among the top collaborators of Liyan Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liyan Cui. Liyan Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhan, Shaohua, et al.. (2025). The Ubiquitin Ligase CHIP Accelerates Papillary Thyroid Carcinoma Metastasis via the Transgelin–Matrix Metalloproteinase-9 Axis. Journal of Proteome Research. 24(2). 589–598.

Wu, Yufeng, Yahui Zhang, Lin Zeng, et al.. (2025). Diagnostic Value of Umbilical Cord Blood Interleukin-6 Level in Premature Infants with Early-Onset Sepsis. Children. 12(3). 301–301. 1 indexed citations

Yang, Shuo, Qian Zhang, Qi Liu, et al.. (2025). Research advances in epigenetic modifications and post-translational modifications in endothelial-mesenchymal transition. Epigenetics & Chromatin. 18(1). 80–80.

Wang, Tiancheng, et al.. (2024). Abnormal blood concentration changes in a 71-year-old female who survived a 10,000mg overdose of clozapine: a case report. BMC Psychiatry. 24(1). 123–123. 2 indexed citations

Zhang, Xiaotian, Xiaolong Li, Haihong Zhang, et al.. (2024). Barriers to implementation of preoperative urostomy site marking in nurse-physician cooperation: A qualitative study based on the Theoretical Domains Framework. Asia-Pacific Journal of Oncology Nursing. 12. 100634–100634.

Tian, Wenmin, et al.. (2024). Deep proteomic analysis of obstetric antiphospholipid syndrome by DIA-MS of extracellular vesicle enriched fractions. Communications Biology. 7(1). 99–99. 7 indexed citations

Xu, Zhen, et al.. (2024). Understanding the heterogeneity and dysfunction of HDL in chronic kidney disease: insights from recent reviews. BMC Nephrology. 25(1). 400–400. 6 indexed citations

Yang, Ping, Chao Liu, Pengcheng Du, et al.. (2024). ST218 Klebsiella pneumoniae became a high-risk clone for multidrug resistance and hypervirulence. BMC Microbiology. 24(1). 56–56.

Liu, Qi, et al.. (2023). Pyroptosis-triggered pathogenesis: New insights on antiphospholipid syndrome. Frontiers in Immunology. 14. 1155222–1155222. 6 indexed citations

10.

Wang, Fei, et al.. (2023). Serum exosomal microRNA-1258 may as a novel biomarker for the diagnosis of acute exacerbations of chronic obstructive pulmonary disease. Scientific Reports. 13(1). 18332–18332. 7 indexed citations

11.

Liu, Qi, et al.. (2023). High-throughput sequencing technology facilitates the discovery of novel biomarkers for antiphospholipid syndrome. Frontiers in Immunology. 14. 1128245–1128245. 4 indexed citations

12.

Zhang, Yuan, et al.. (2022). Improved diagnosis of rheumatoid arthritis using an artificial neural network. Scientific Reports. 12(1). 9810–9810. 26 indexed citations

13.

Yang, Ping, Chao Liu, Jia‐Jia Zheng, et al.. (2022). Clinical Outcomes, Microbiological Characteristics and Risk Factors for Difficult-to-Treat Resistance to Klebsiella pneumoniae Infection. Infection and Drug Resistance. Volume 15. 5959–5969. 8 indexed citations

14.

Liu, Qi, et al.. (2022). Epigenetics-mediated pathological alternations and their potential in antiphospholipid syndrome diagnosis and therapy. Autoimmunity Reviews. 21(8). 103130–103130. 10 indexed citations

15.

Qiao, Jiao & Liyan Cui. (2022). Multi-Omics Techniques Make it Possible to Analyze Sepsis-Associated Acute Kidney Injury Comprehensively. Frontiers in Immunology. 13. 905601–905601. 27 indexed citations

16.

Cui, Liyan, et al.. (2021). M-BLUE protocol for coronavirus disease-19 (COVID-19) patients: interobserver variability and correlation with disease severity. Clinical Radiology. 76(5). 379–383. 14 indexed citations

17.

Si, Wenzhe, et al.. (2020). SET7/9 promotes multiple malignant processes in breast cancer development via RUNX2 activation and is negatively regulated by TRIM21. Cell Death and Disease. 11(2). 151–151. 41 indexed citations

18.

Cai, Yan, Liyan Cui, Wen Tang, et al.. (2019). Suppression of Gut Bacterial Translocation Ameliorates Vascular Calcification through Inhibiting Toll-Like Receptor 9-Mediated BMP-2 Expression. Oxidative Medicine and Cellular Longevity. 2019. 1–12. 11 indexed citations

19.

Si, Wenzhe, Xujun Liu, Rui Wei, et al.. (2019). MTA2-mediated inhibition of PTEN leads to pancreatic ductal adenocarcinoma carcinogenicity. Cell Death and Disease. 10(3). 206–206. 18 indexed citations

20.

Zhang, Wenjing, Shuo Yang, Liyan Cui, & Jie Zhang. (2016). Neutrophil gelatinase-associated lipocalin worsens ischemia/reperfusion damage of kidney cells by autophagy. Renal Failure. 38(7). 1136–1140. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact